RetinalGenix Technologies RTGN
OTC RTGN
$3.99 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

RetinalGenix Technologies (RTGN) Liabilities and Shareholders Equity (2020 - 2026)

Updated

RetinalGenix Technologies' Liabilities and Shareholders Equity came in at $32,215 for Q2 2026, up 284.1% from $8,388 a year earlier and up 455.0% from the prior quarter.

Analysis

RetinalGenix Technologies (RTGN) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, RetinalGenix Technologies' Liabilities and Shareholders Equity was $21,041, up 40.8% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of -19.2% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $14,946 in FY2024, $156.00 in FY2023 (-46.9%), $294.00 in FY2022 (-94.1%) and $4,947 in FY2021 (-91.9%).
  • The Q2 2026 figure represents the highest quarterly Liabilities and Shareholders Equity since Q3 2024.
  • Year-over-year, Liabilities and Shareholders Equity increased in two of the last six quarters, with growth averaging 2.4%.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q1 2024 (growth of 556.0%), and the weakest in Q3 2023 (a decline of 94.3%).
  • Business Quant data shows RTGN's Liabilities and Shareholders Equity at $5,805 (Q1 2026), $21,041 (Q4 2025) and $7,001 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 109.22 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 20.88 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 93.31 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 45.22 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 13.87 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 50.73 Bn
10 RetinalGenix Technologies 75.19 Mn 75.14 Mn - 32,215.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32,215.00
Mar 31, 2026 5,805.00
Dec 31, 2025 21,041.00
Sep 30, 2025 7,001.00
Jun 30, 2025 8,388.00
Mar 31, 2025 11,931.00
Dec 31, 2024 14,946.00
Sep 30, 2024 88,854.00
Jun 30, 2024 87,019.00
Mar 31, 2024 50,517.00
Dec 31, 2023 156.00
Sep 30, 2023 225.00
Jun 30, 2023 2,119.00
Mar 31, 2023 7,701.00
Dec 31, 2022 294.00
Sep 30, 2022 3,914.00
Jun 30, 2022 27.00
Mar 31, 2022 2,555.00
Dec 31, 2021 4,947.00
Sep 30, 2021 36,578.00
API Access

RetinalGenix Technologies Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RTGN&period=max&api_key=YOUR_API_KEY